Companies: 10,795·Total market cap: $144.5T
FusionPharm, Inc.

FusionPharm, Inc.

FSPMOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$1259
P/E Ratio
52W High$0.0001
52W Low$0.0001

FusionPharm, Inc. (FSPM) Market Cap & Net Worth

Live market cap, enterprise value, and global rank — multi-year chart and annual table below.

fspm · market cap & enterprise value · FMP · as of Jun 5, 2026

Core market cap & key metrics

As of Jun 5, 2026, FusionPharm, Inc. (FSPM) has a market cap — also referred to as its net worth or valuation — of $1,259, making it one of the top most valuable companies globally. Market Cap = $0.00 × shares outstanding.

Market Cap (Net Worth)$1,259fspm market cap 2026
Enterprise ValuemktCap + debt − cash
1-Year Changevs one year ago
Global Rankinglargest company by mkt cap
All-Time High$0fspm highest market cap ever
Stock Price$0.00OTC · Jun 5, 2026
How is Market Cap calculated?Market Cap = Stock Price × Shares Outstanding

About Market Cap, Net Worth & Valuation

FusionPharm, Inc. (FSPM) has a market cap — also referred to as its net worth or valuation — of $1,259 as of Jun 5, 2026, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.

FusionPharm, Inc. reached its all-time high market cap of $0 on —. Comparing the FusionPharm, Inc. market cap history illustrates one of the most extraordinary corporate growth stories.

Investors frequently compare FusionPharm, Inc. net worth vs peers and ask how FusionPharm, Inc. valuation compares to other countries. Its market cap reflects continued investor confidence.

Data: FMP · year-end market cap · not investment advice

Frequently Asked Questions

FSPM market cap · 6 questions

FusionPharm, Inc.'s net worth — measured as market capitalization — is $1,259 as of Jun 5, 2026. It ranks #0 globally. Market Cap = $$0.00 (price) × shares outstanding.

FSPM net worth 2026market cap vs book valuelargest companies by market cap
Data: Financial Modeling Prep · Market cap updates daily · For informational purposes only, not investment advice.